Phase  ||| S:0 E:6 ||| NN
separation  ||| S:6 E:17 ||| NN
behavior  ||| S:17 E:26 ||| NN
of  ||| S:26 E:29 ||| IN
mixed  ||| S:29 E:35 ||| JJ
lipid  ||| S:35 E:41 ||| NN
systems  ||| S:41 E:49 ||| NNS
at  ||| S:49 E:52 ||| IN
neutral  ||| S:52 E:60 ||| JJ
and  ||| S:60 E:64 ||| CC
low  ||| S:64 E:68 ||| JJ
pH ||| S:68 E:70 ||| NN
:  ||| S:70 E:72 ||| :
coarse-grained  ||| S:72 E:87 ||| JJ
simulations  ||| S:87 E:99 ||| NNS
with  ||| S:99 E:104 ||| IN
DMD ||| S:104 E:107 ||| NNP
/ ||| S:107 E:108 ||| NNP
LIME  ||| S:108 E:113 ||| NNP
We  ||| S:113 E:116 ||| PRP
extend  ||| S:116 E:123 ||| VBP
LIME ||| S:123 E:127 ||| NNP
,  ||| S:127 E:129 ||| ,
an  ||| S:129 E:132 ||| DT
intermediate  ||| S:132 E:145 ||| JJ
resolution ||| S:145 E:155 ||| NN
,  ||| S:155 E:157 ||| ,
implicit  ||| S:157 E:166 ||| JJ
solvent  ||| S:166 E:174 ||| JJ
model  ||| S:174 E:180 ||| NN
for  ||| S:180 E:184 ||| IN
phospholipids  ||| S:184 E:198 ||| VBG
previously  ||| S:198 E:209 ||| RB
used  ||| S:209 E:214 ||| VBN
in  ||| S:214 E:217 ||| IN
discontinuous  ||| S:217 E:231 ||| JJ
molecular  ||| S:231 E:241 ||| JJ
dynamics  ||| S:241 E:250 ||| NNS
simulations  ||| S:250 E:262 ||| VBN
of  ||| S:262 E:265 ||| IN
1,2-dipalmitoyl-sn-glycero-3-phosphocholine  ||| S:265 E:309 ||| NNP
( ||| S:309 E:310 ||| -LRB-
DPPC ||| S:310 E:314 ||| NNP
)  ||| S:314 E:316 ||| -RRB-
bilayer  ||| S:316 E:324 ||| JJ
formation  ||| S:324 E:334 ||| NN
at  ||| S:334 E:337 ||| IN
325  ||| S:337 E:341 ||| CD
K ||| S:341 E:342 ||| NNP
,  ||| S:342 E:344 ||| ,
to  ||| S:344 E:347 ||| TO
the  ||| S:347 E:351 ||| DT
description  ||| S:351 E:363 ||| NN
of  ||| S:363 E:366 ||| IN
the  ||| S:366 E:370 ||| DT
geometry  ||| S:370 E:379 ||| NN
and  ||| S:379 E:383 ||| CC
energetics  ||| S:383 E:394 ||| NN
of  ||| S:394 E:397 ||| IN
1,2-distearoyl-sn-glycero-3-phospho-L-serine  ||| S:397 E:442 ||| NNP
( ||| S:442 E:443 ||| -LRB-
DSPS ||| S:443 E:447 ||| NNP
)  ||| S:447 E:449 ||| -RRB-
and  ||| S:449 E:453 ||| CC
1,2-dihenarachidoyl-sn-glycero-3-phosphocholine  ||| S:453 E:501 ||| NNP
( ||| S:501 E:502 ||| -LRB-
21PC ||| S:502 E:506 ||| NNP
)  ||| S:506 E:508 ||| -RRB-
and  ||| S:508 E:512 ||| CC
mixtures  ||| S:512 E:521 ||| JJ
thereof  ||| S:521 E:529 ||| NN
at  ||| S:529 E:532 ||| IN
both  ||| S:532 E:537 ||| DT
neutral  ||| S:537 E:545 ||| JJ
and  ||| S:545 E:549 ||| CC
low  ||| S:549 E:553 ||| JJ
pH  ||| S:553 E:556 ||| NN
at  ||| S:556 E:559 ||| IN
310  ||| S:559 E:563 ||| CD
K.  ||| S:563 E:566 ||| CD
A  ||| S:566 E:568 ||| DT
multiscale  ||| S:568 E:579 ||| JJ
modeling  ||| S:579 E:588 ||| JJ
approach  ||| S:588 E:597 ||| NN
is  ||| S:597 E:600 ||| VBZ
used  ||| S:600 E:605 ||| VBN
to  ||| S:605 E:608 ||| TO
calculate  ||| S:608 E:618 ||| VB
the  ||| S:618 E:622 ||| DT
LIME  ||| S:622 E:627 ||| NNP
parameters  ||| S:627 E:638 ||| NNS
from  ||| S:638 E:643 ||| IN
atomistic  ||| S:643 E:653 ||| JJ
simulation  ||| S:653 E:664 ||| JJ
data  ||| S:664 E:669 ||| NNS
on  ||| S:669 E:672 ||| IN
a  ||| S:672 E:674 ||| DT
mixed  ||| S:674 E:680 ||| JJ
DPPC ||| S:680 E:684 ||| NNP
/ ||| S:684 E:685 ||| NNP
DSPS  ||| S:685 E:690 ||| NNP
system  ||| S:690 E:697 ||| NN
at  ||| S:697 E:700 ||| IN
different  ||| S:700 E:710 ||| JJ
pH  ||| S:710 E:713 ||| JJ
values ||| S:713 E:719 ||| NNS
.  ||| S:719 E:721 ||| .
In  ||| S:721 E:724 ||| IN
the  ||| S:724 E:728 ||| DT
model ||| S:728 E:733 ||| NN
,  ||| S:733 E:735 ||| ,
17  ||| S:735 E:738 ||| CD
coarse-grained  ||| S:738 E:753 ||| JJ
sites  ||| S:753 E:759 ||| NNS
represent  ||| S:759 E:769 ||| VBP
DSPS  ||| S:769 E:774 ||| NNP
and  ||| S:774 E:778 ||| CC
18  ||| S:778 E:781 ||| CD
coarse-grained  ||| S:781 E:796 ||| JJ
sites  ||| S:796 E:802 ||| NNS
represent  ||| S:802 E:812 ||| VBP
21PC ||| S:812 E:816 ||| CD
.  ||| S:816 E:818 ||| .
Each  ||| S:818 E:823 ||| DT
of  ||| S:823 E:826 ||| IN
these  ||| S:826 E:832 ||| DT
coarse-grained  ||| S:832 E:847 ||| JJ
sites  ||| S:847 E:853 ||| NNS
is  ||| S:853 E:856 ||| VBZ
classified  ||| S:856 E:867 ||| VBN
as  ||| S:867 E:870 ||| IN
1  ||| S:870 E:872 ||| CD
of  ||| S:872 E:875 ||| IN
9  ||| S:875 E:877 ||| CD
types ||| S:877 E:882 ||| NNS
.  ||| S:882 E:884 ||| .
LIME ||| S:884 E:888 ||| NNP
/ ||| S:888 E:889 ||| NNP
DMD  ||| S:889 E:893 ||| NNP
simulations  ||| S:893 E:905 ||| NNS
of  ||| S:905 E:908 ||| IN
equimolar  ||| S:908 E:918 ||| JJ
bilayers  ||| S:918 E:927 ||| NNS
show  ||| S:927 E:932 ||| VBP
the  ||| S:932 E:936 ||| DT
following ||| S:936 E:945 ||| NN
:  ||| S:945 E:947 ||| :
( ||| S:947 E:948 ||| -LRB-
1 ||| S:948 E:949 ||| LS
)  ||| S:949 E:951 ||| -RRB-
21PC ||| S:951 E:955 ||| NNP
/ ||| S:955 E:956 ||| NNP
DSPS  ||| S:956 E:961 ||| NNP
bilayers  ||| S:961 E:970 ||| NN
with  ||| S:970 E:975 ||| IN
and  ||| S:975 E:979 ||| CC
without  ||| S:979 E:987 ||| IN
surface  ||| S:987 E:995 ||| NN
area  ||| S:995 E:1000 ||| NN
restrictions  ||| S:1000 E:1013 ||| NNS
separate  ||| S:1013 E:1022 ||| VBP
faster  ||| S:1022 E:1029 ||| RBR
at  ||| S:1029 E:1032 ||| IN
low  ||| S:1032 E:1036 ||| JJ
pH  ||| S:1036 E:1039 ||| NN
than  ||| S:1039 E:1044 ||| IN
at  ||| S:1044 E:1047 ||| IN
neutral  ||| S:1047 E:1055 ||| JJ
pH ||| S:1055 E:1057 ||| NN
,  ||| S:1057 E:1059 ||| ,
( ||| S:1059 E:1060 ||| -LRB-
2 ||| S:1060 E:1061 ||| LS
)  ||| S:1061 E:1063 ||| -RRB-
21PC ||| S:1063 E:1067 ||| NNP
/ ||| S:1067 E:1068 ||| NNP
DSPS  ||| S:1068 E:1073 ||| NNP
systems  ||| S:1073 E:1081 ||| NNS
separate  ||| S:1081 E:1090 ||| JJ
at  ||| S:1090 E:1093 ||| IN
approximately  ||| S:1093 E:1107 ||| RB
the  ||| S:1107 E:1111 ||| DT
same  ||| S:1111 E:1116 ||| JJ
rate  ||| S:1116 E:1121 ||| NN
regardless  ||| S:1121 E:1132 ||| RB
of  ||| S:1132 E:1135 ||| IN
whether  ||| S:1135 E:1143 ||| IN
they  ||| S:1143 E:1148 ||| PRP
are  ||| S:1148 E:1152 ||| VBP
subjected  ||| S:1152 E:1162 ||| VBN
to  ||| S:1162 E:1165 ||| TO
surface  ||| S:1165 E:1173 ||| VB
area  ||| S:1173 E:1178 ||| NN
restrictions ||| S:1178 E:1190 ||| NNS
,  ||| S:1190 E:1192 ||| ,
and  ||| S:1192 E:1196 ||| CC
( ||| S:1196 E:1197 ||| -LRB-
3 ||| S:1197 E:1198 ||| LS
)  ||| S:1198 E:1200 ||| -RRB-
bilayers  ||| S:1200 E:1209 ||| NN
with  ||| S:1209 E:1214 ||| IN
a  ||| S:1214 E:1216 ||| DT
molar  ||| S:1216 E:1222 ||| JJ
ratio  ||| S:1222 E:1228 ||| NN
of  ||| S:1228 E:1231 ||| IN
9 ||| S:1231 E:1232 ||| CD
: ||| S:1232 E:1233 ||| :
1  ||| S:1233 E:1235 ||| CD
( ||| S:1235 E:1236 ||| -LRB-
21PC ||| S:1236 E:1240 ||| NNP
: ||| S:1240 E:1241 ||| :
DSPS ||| S:1241 E:1245 ||| NNP
)  ||| S:1245 E:1247 ||| -RRB-
phase  ||| S:1247 E:1253 ||| VB
separate  ||| S:1253 E:1262 ||| JJ
to  ||| S:1262 E:1265 ||| TO
form  ||| S:1265 E:1270 ||| VB
heterogeneous  ||| S:1270 E:1284 ||| JJ
domains  ||| S:1284 E:1292 ||| NN
faster  ||| S:1292 E:1299 ||| RBR
at  ||| S:1299 E:1302 ||| IN
low  ||| S:1302 E:1306 ||| JJ
pH  ||| S:1306 E:1309 ||| NN
than  ||| S:1309 E:1314 ||| IN
at  ||| S:1314 E:1317 ||| IN
neutral  ||| S:1317 E:1325 ||| JJ
pH ||| S:1325 E:1327 ||| NN
.  ||| S:1327 E:1329 ||| .
Our  ||| S:1329 E:1333 ||| PRP$
results  ||| S:1333 E:1341 ||| NNS
are  ||| S:1341 E:1345 ||| VBP
consistent  ||| S:1345 E:1356 ||| JJ
with  ||| S:1356 E:1361 ||| IN
experimental  ||| S:1361 E:1374 ||| JJ
findings  ||| S:1374 E:1383 ||| NNS
of  ||| S:1383 E:1386 ||| IN
Sofou  ||| S:1386 E:1392 ||| NNP
and  ||| S:1392 E:1396 ||| CC
co-workers  ||| S:1396 E:1407 ||| NNS
( ||| S:1407 E:1408 ||| -LRB-
Bandekar  ||| S:1408 E:1417 ||| FW
et  ||| S:1417 E:1420 ||| FW
al ||| S:1420 E:1422 ||| FW
.  ||| S:1422 E:1424 ||| .
Mol ||| S:1424 E:1427 ||| NNP
.  ||| S:1427 E:1429 ||| .
Pharmaceutics ||| S:1429 E:1442 ||| NNP
,  ||| S:1442 E:1444 ||| ,
2013 ||| S:1444 E:1448 ||| CD
,  ||| S:1448 E:1450 ||| ,
10 ||| S:1450 E:1452 ||| CD
,  ||| S:1452 E:1454 ||| ,
152-160 ||| S:1454 E:1461 ||| NNP
;  ||| S:1461 E:1463 ||| :
Karve  ||| S:1463 E:1469 ||| FW
et  ||| S:1469 E:1472 ||| FW
al ||| S:1472 E:1474 ||| FW
.  ||| S:1474 E:1476 ||| .
Biomaterials ||| S:1476 E:1488 ||| NNP
,  ||| S:1488 E:1490 ||| ,
2010 ||| S:1490 E:1494 ||| CD
,  ||| S:1494 E:1496 ||| ,
31 ||| S:1496 E:1498 ||| CD
,  ||| S:1498 E:1500 ||| ,
4409-4416 ||| S:1500 E:1509 ||| CD
)  ||| S:1509 E:1511 ||| -RRB-
that  ||| S:1511 E:1516 ||| IN
more  ||| S:1516 E:1521 ||| JJR
doxorubicin  ||| S:1521 E:1533 ||| NN
is  ||| S:1533 E:1536 ||| VBZ
released  ||| S:1536 E:1545 ||| VBN
from  ||| S:1545 E:1550 ||| IN
21PC ||| S:1550 E:1554 ||| NNP
/ ||| S:1554 E:1555 ||| NNP
DSPS  ||| S:1555 E:1560 ||| NNP
liposomes  ||| S:1560 E:1570 ||| NN
at  ||| S:1570 E:1573 ||| IN
low  ||| S:1573 E:1577 ||| JJ
pH  ||| S:1577 E:1580 ||| NN
than  ||| S:1580 E:1585 ||| IN
at  ||| S:1585 E:1588 ||| IN
neutral  ||| S:1588 E:1596 ||| JJ
pH ||| S:1596 E:1598 ||| NN
,  ||| S:1598 E:1600 ||| ,
presumably  ||| S:1600 E:1611 ||| RB
because  ||| S:1611 E:1619 ||| IN
greater  ||| S:1619 E:1627 ||| JJR
phase  ||| S:1627 E:1633 ||| NN
separation  ||| S:1633 E:1644 ||| NN
is  ||| S:1644 E:1647 ||| VBZ
achieved  ||| S:1647 E:1656 ||| VBN
at  ||| S:1656 E:1659 ||| IN
low  ||| S:1659 E:1663 ||| JJ
pH  ||| S:1663 E:1666 ||| NN
than  ||| S:1666 E:1671 ||| IN
at  ||| S:1671 E:1674 ||| IN
neutral  ||| S:1674 E:1682 ||| JJ
pH ||| S:1682 E:1684 ||| NN
.  ||| S:1684 E:1686 ||| .
These  ||| S:1686 E:1692 ||| DT
are  ||| S:1692 E:1696 ||| VBP
the  ||| S:1696 E:1700 ||| DT
first  ||| S:1700 E:1706 ||| JJ
molecular-level  ||| S:1706 E:1722 ||| JJ
simulations  ||| S:1722 E:1734 ||| NNS
of  ||| S:1734 E:1737 ||| IN
the  ||| S:1737 E:1741 ||| DT
phase  ||| S:1741 E:1747 ||| NN
separation  ||| S:1747 E:1758 ||| NN
in  ||| S:1758 E:1761 ||| IN
mixed  ||| S:1761 E:1767 ||| JJ
lipid  ||| S:1767 E:1773 ||| NNS
bilayers  ||| S:1773 E:1782 ||| VBP
induced  ||| S:1782 E:1790 ||| VBN
by  ||| S:1790 E:1793 ||| IN
a  ||| S:1793 E:1795 ||| DT
change  ||| S:1795 E:1802 ||| NN
in  ||| S:1802 E:1805 ||| IN
pH ||| S:1805 E:1807 ||| JJ
.  ||| S:1807 E:1809 ||| .
